Epilepsy
Epilepsy
Epilepsy affects about 2.5 million Americans, and results in an estimated annual cost of $15.5 billion in medical costs and lost earnings and production. About 10% of Americans will experience a seizure sometime during their lifetime, and about 3% will have had a diagnosis of epilepsy by age 80.
Most recent articles
Do New Antiepileptic Drugs with Novel Mechanisms of Action Suggest Reconsideration of Rational Polypharmacy?
Epilepsy is a common, complex, and chronic neurologic disorder affecting an estimated 0.5–1% of the global population or approximately 50 million...
Neurostimulation as a Treatment Option for Epilepsy
Vagus Nerve Stimulation Electrical stimulation of the 10th cranial nerve or vagus nerve stimulation (VNS) has become a valuable option...
The Ketogenic Diet in the Treatment of Childhood Epilepsy
The ketogenic diet (KD) is a high-fat diet used in the management of childhood epilepsy. It was determined in the early part of last...
Mayo Clinic Designated Top Epilepsy Treatment Center
Recognizing the breadth of services offered at Mayo Clinic by awarding such a title is one way patients and their medical insurers can gain...
Medical Guidelines
To assess the yield and value of various diagnostic procedures such as electroencephalography (EEG), computed tomography (CT), or magnetic resonance imaging (MRI), and specific laboratory or...
To assess the evidence demonstrating efficacy, tolerability, and safety of seven new antiepileptic drugs (AEDs) (gabapentin, lamotrigine, topiramate, tiagabine, oxcarbazepine, levetiracetam, and...
